Evidence map›Paper›PMID 36074767›Full record

ArticlePloS one2022

Predominance of t355/ST152/SCCmec V clonal type among PVL-positive MRSA isolates in a tertiary care hospital in Belgrade, Serbia.

Bojan Rakonjac, Zorica Lepšanović, Vesna Šuljagić, Branko Jovčić, Milan Kojić, Anders Rhod Larsen, Momčilo Đurić, Ivana Ćirković

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Bojan RakonjacMilitary Medical Academy, Belgrade, Serbia.
Zorica LepšanovićMilitary Medical Academy, Belgrade, Serbia.ORCID 0000-0002-1716-4963
Vesna ŠuljagićMilitary Medical Academy, Belgrade, Serbia.
Branko JovčićInstitute of Molecular Genetics and Genetic Engineering, Univerity of Belgrade, Belgrade, Serbia.
Milan KojićInstitute of Molecular Genetics and Genetic Engineering, Univerity of Belgrade, Belgrade, Serbia.ORCID 0000-0003-0808-6358
Anders Rhod LarsenDepartment of Microbiological Surveillance and Research, Statens Serum Institut, Copenhagen, Denmark.
Momčilo ĐurićMilitary Medical Academy, Belgrade, Serbia.
Ivana ĆirkovićUniversity of Belgrade-Faculty of Medicine, Institute of Microbiology and Immunology, Belgrade, Serbia.ORCID 0000-0003-1515-1824
Military Medical Academy · RSUniversity of Belgrade · RSStatens Serum Institut · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) is continually changing. Frequency of genotypes typical for community-associated MRSA (CA-MRSA) is increasing in hospitals, as well as resistance to antimicrobial agents. Moreover, different clones predominate in different geographic regions, and temporal shifts occur in the predominant clonal type. The aim of this study was to estimate the prevalence of MRSA, CA-MRSA and PVL-positive MRSA isolates from patients hospitalised in the Military Medical Academy (MMA) and from outpatients, and to perform genotyping of PVL-positive MRSA isolates. MRSA isolates were obtained by standard microbiological techniques. PVL-positive MRSA were detected by single PCR. Determination of SCCmec types in MRSA isolates was done using multiplex PCR and genotyping of PVL-positive MRSA by PFGE, MLST and spa typing. The prevalence of MRSA among S. aureus isolates from different clinical specimens was 43.4%. In outpatients the prevalence of MRSA was 3.2%. SCCmec types specific for CA-MRSA were found in 26% of MRSA isolates from hospitalised patients. In groups, hospitalised patients and outpatients, the prevalence of PVL-positive MRSA isolates was 4%, and all of them harboured SCCmec type V genetic element. PFGE revealed minor differences between four groups of PVL-positive MRSA isolates, but all of them belonged to ST152, and all except one were of the t355 spa type. High prevalence of MRSA and CA-MRSA in MMA, especially the presence of PVL-positive CA-MRSA, represent a serious health threat for patients. Genotype t355/ST152/SCCmec V is the dominant MRSA clone among PVL-positive CA-MRSA.

Indexed as

Bacterial ToxinsMethicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsAnti-Bacterial AgentsGenotypeHumansLeukocidinsMicrobial Sensitivity TestsMultilocus Sequence TypingSerbiaStaphylococcus aureusTertiary Care CentersAnti-Bacterial AgentsBacterial ToxinsLeukocidins

Identifiers

PMID36074767
PMCPMC9455871
OpenAlexW4294992133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.